More news
- Nigeria’s paint industry navigates regulatory changes and economic challenges amid p...
- Focus on the global coatings market: Global coatings market outlook
- Ask Joe Powder – October 2024
- Chinese paint majors look to domestic consumer sales as commercial real estate slumps
- Architectural coatings in Nepal and Bhutan
Arkema has announced the proposed acquisition of Permoseal in South Africa, one of the leaders in adhesive solutions for woodworking, packaging, construction and DIY. Its well-known brands, including Alcolin®, and its extensive range of high-performance adhesive solutions will complement Bostik’s offering in the region, strengthening their positions in South Africa’s and Sub-Saharan Africa’s dynamic industrial, construction and DIY markets.
Permoseal offers a large portfolio of technical and sustainable solutions for packaging, as well as for wall and floor preparation, renovation and waterproofing. Leveraging its well-known brands, Permoseal has a strong presence in South Africa’s retail chains and is the exclusive distributor of the Bostik® and Evo-Stik® brands in the region. The company, with sales estimated at €44M in 2021, operates two production plants in the country.
With this proposed acquisition, Bostik will significantly strengthen its presence in South Africa in the DIY adhesives sector, in which the Bostik® and Den Braven® brands are already well established. The complementarity of product portfolios will allow Bostik to broaden its customer offering in the South African construction market, and continue its expansion in the region, benefiting in particular from strongly growing demand in the building renovation market. The project will also enable Bostik to consolidate its position in packaging adhesives and expand its offering of sustainable solutions for the industrial sector in the South African market.
This bolt-on acquisition is in line with the strategy to grow the Group’s Adhesive Solutions segment and offers many development synergies. This project, which is subject to approval by antitrust authorities, should be finalised in Q2, 2022.